Medicare Spending on Drugs With Accelerated Approval, 2015-2019

被引：10

作者：

Rome, Benjamin N. ^{[1
,2
]}

Feldman, William B. ^{[1
,2
,3
]}

Kesselheim, Aaron S. ^{[1
,2
]}

机构：

[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA

来源：

JAMA HEALTH FORUM | 2021年 / 2卷 / 12期

关键词：

D O I：

10.1001/jamahealthforum.2021.3937

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

[No abstract available]

引用

页数：4

共 6 条

[1]

Cubanski J., 2021, RELATIVELY FEW DRUGS

[2] Estimating Rebates and Other Discounts Received by Medicare Part D [J].

Feldman, William B. ;

Rome, Benjamin N. ;

Raimond, Veronique C. ;

Gagne, Joshua J. ;

Kesselheim, Aaron S. .

JAMA HEALTH FORUM, 2021, 2 (06) :E210626

[3] Accelerated Approval and Expensive Drugs - A Challenging Combination [J].

Gellad, Walid F. ;

Kesselheim, Aaron S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (21) :2001-2004

[4] Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective obser-vational study [J].

Gyawali, Bishal ;

Rome, Benjamin N. ;

Kesselheim, Aaron S. .

BMJ-BRITISH MEDICAL JOURNAL, 2021, 374

[5] Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration [J].

Naci, Huseyin ;

Smalley, Katelyn R. ;

Kesselheim, Aaron S. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (07) :626-636

[6]

US Food and Drug Adminstration (FDA), 2021, ACC APPR

← 1 →